CDC73 and tumor of parathyroid gland: Among the included studies, CDC73 mutation and parafibromin immunohistochemical (IHC) results for patients with parathyroid neoplasms were reviewed, and possible reasons for the inconsistency between the parafibromin staining loss and CDC73 mutation were explored.